Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis

Journal of the American Academy of Dermatology
Benjamin LockshinJoseph F Merola

Abstract

In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17-mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.

Citations

Feb 1, 2019·Journal of Atherosclerosis and Thrombosis·Yoko NishidaUNKNOWN JACC Study Group
Feb 5, 2019·British Journal of Pharmacology·Erin B TaylorMichael J Ryan
Nov 2, 2019·Bioscience Reports·Xiran LinZhiqi Song
Jan 17, 2020·British Journal of Pharmacology·Antigone LazouIoanna Andreadou
Sep 10, 2019·The British Journal of Dermatology·P Gisondi
Apr 22, 2020·Immunotherapy·Cristina López-Sánchez, Lluís Puig
Feb 20, 2020·International Journal of Molecular Sciences·Masutaka FurueTakeshi Nakahara
Aug 23, 2020·Immunologic Research·Binbin LiWeirong Fang
Jul 31, 2018·Frontiers in Immunology·Gilda VarricchiGianni Marone
Mar 13, 2020·Frontiers in Pharmacology·Paolo GisondiCristina Albanesi
May 19, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Brittany WeberMarcelo Di Carli
Nov 25, 2018·International Journal of Impotence Research·Shankun ZhaoZhigang Zhao
Oct 4, 2020·Nursing·Christine M Galante
Oct 14, 2019·The Canadian Journal of Cardiology·George MakavosEvangelia Papadavid
Nov 30, 2019·The Journal of Investigative Dermatology·María Teresa Sanz-MartínezLluís Puig
Jun 18, 2021·American Journal of Hypertension·Jessica Youwakim, Hélène Girouard
Sep 2, 2021·Current Atherosclerosis Reports·Brittany WeberMichael S Garshick
Sep 25, 2021·Journal of the American Heart Association·Daein ChoiHyun-Sun Yoon
Jun 10, 2020·Korean journal of family medicine·Adrian Martinez-MorenoVeronica Garza-Rodriguez
Jul 14, 2021·The British Journal of Dermatology·K NavrazhinaJ G Krueger
Nov 23, 2021·Acta Dermato-venereologica·Stefanie HölskenWiebke Sondermann
Dec 10, 2021·Frontiers in Nutrition·Chaonan SunZhu Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of Scleroderma and Related Disorders
Ami A Shah, Livia Casciola-Rosen
Current Problems in Dermatology
Angela Yen MooreTodd Moore
Current Osteoporosis Reports
Manasi AgrawalMone Zaidi
© 2022 Meta ULC. All rights reserved